Stockreport

J&J's new psoriasis pill to rival AbbVie's Skyrizi: BNP Paribas [Seeking Alpha]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Icotyde, a newly approved plaque psoriasis pill developed by Johnson & Johnson ( JNJ ) and Protagonist Therapeutics (PRGX). J&J ( JNJ ) and Fresh Stock Ideas, Every [Read more]